The US FDA has declined to approve Zealand Pharma's dasiglucagon for hypoglycaemia in infants with congenital hyperinsulinism ...

The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 ...

Sharad Avasthi, from SMIFS, shares an in-depth analysis of the entire pharma sector, highlighting improved margins driven by ...

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal ...

Jonathan Chang, an analyst from Leerink Partners, maintained the Buy rating on Vincerx Pharma Inc (VINC – Research Report). The ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million ...

Skyrizi had an estimated national TV ad spend of $93.7 million — the highest amount of any brand in the top 10 during this ...

Protecting the rights of Americans is my top priority. I believe in the power of the free-market and the importance of limited government overreach. However, today our health care system is under ...

Eversana is increasing its reach across the global pharmaceutical industry. | Eversana is increasing its reach across the ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...

India's pharmaceutical and meditech exports have become the fourth-largest export sector, with 16 blockbuster drugs in the pipeline. Despite global slowdown concerns, the sector is experiencing double ...

But the YoY growth is expected to decline for the Indian Pharmaceutical Market (IPM), projected at approximately 8 per cent, ...